Early indicators of prognosis in fulminant hepatic failure: an assessment of the King's criteria
about
Interventions for paracetamol (acetaminophen) overdoseAcute liver failure including acetaminophen overdoseHematologic disorders associated with hepatitis C virus infection and their management.Hepatitis C and alcohol.Prognostic indicators for acute liver failure development and mortality in patients with hepatitis A: consecutive case analysis.Acute liver failure: established and putative hepatitis viruses and therapeutic implications.Alcohol exposure and paracetamol-induced hepatotoxicity.Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection.Hepatitis C in clinical practice.Understanding lactic acidosis in paracetamol (acetaminophen) poisoning.Prediction of poor outcome in patients with acute liver failure-systematic review of prediction modelsAdvances in the treatment of hepatitis C: combination antiviral therapy with interferon alfa-2b and ribavirin.A toxicologist's guide to biomarkers of hepatic response.Evidence and consequences of spectrum bias in studies of criteria for liver transplant in paracetamol hepatotoxicity.A potential hidden source of hepatitis C infection among noninjecting drug users.A toxicologist's guide to studying diagnostic tests.Prediction of outcome and selection of the liver transplantat candidate in acute liver failureOutcome from molecular adsorbent recycling system (MARS) liver dialysis following drug-induced liver failure.King's College Hospital Criteria for non-acetaminophen induced acute liver failure in an international cohort of children.Acetaminophen dose does not predict outcome in acetaminophen-induced acute liver failureComparison of the applicability of two prognostic scoring systems in patients with fulminant hepatic failure.Systematic review: acute liver failure - one disease, more than 40 definitions.MicroRNAs as potential circulating biomarkers of drug-induced liver injury: key current and future issues for translation to humans.Scoring systems predict the prognosis of acute-on-chronic hepatitis B liver failure: an evidence-based review.Liver transplantation: need, indications, patient selection and pre-transplant care.Development of a Model to Predict Transplant-free Survival of Patients With Acute Liver Failure.Review article: the management of acute liver failure.LiFe: a liver injury score to predict outcome in critically ill patients.Epidemiology of hepatitis C virus infection in American veterans.MELD score to predict outcome in adult patients with non-acetaminophen-induced acute liver failure.Protein kinase R is increased and is functional in hepatitis C virus-related hepatocellular carcinoma.Unscrambling hepatitis C virus-host interactions.Incidence and treatment of hepatitis C virus infection in children with haemophilia in Poland.Promoter/origin structure of the complementary strand of hepatitis C virus genome.Outcome of an optional HCV screening program for blood transfusion recipients in Ireland.Transforming growth factor beta in hepatitis C virus infection: in vivo and in vitro findings.Efficacy of prolonged 5 million units of interferon in combination with ribavirin for relapser patients with chronic hepatitis C.Transplantation of primary and reversibly immortalized human liver cells and other gene therapies in acute liver failure and decompensated chronic liver disease.Comparison of demographic and donation profiles and transfusion-transmissible disease markers and risk rates in previously transfused and nontransfused blood donors.Changes in haemoglobin during interferon alpha-2b plus ribavirin combination therapy for chronic hepatitis C virus infection.
P2860
Q24246166-EC1C9E99-628F-4B12-8CE1-454441239B05Q24647134-56E42131-3E1C-4C65-AA79-6435DD874734Q33349378-D4AB5E06-1AC1-43B7-A7EE-4C3DAAF0A574Q33747334-F508B43D-7E8E-4C5E-A462-F5FDB4D99427Q33822584-648356A5-D46E-47EB-9EDE-939D3FBD261FQ34095674-BEAB28DB-3F97-48B3-89C3-F62A48B6C1E2Q34128040-083A36D1-1D91-4D39-BDA7-80B302038021Q34129547-3F8DCC4A-2D40-458F-9BB7-3388E625C362Q34189713-9A72F873-A4FD-417C-B809-49F8DC536EE4Q34476057-6027860A-806F-4C3A-A08E-F67CA19F6E96Q34525069-7EA4B662-5C2D-4342-93AF-5C0E0EA32E1EQ34586132-18F6A229-1A63-4BCC-8A1C-945AD9F41D44Q34761550-1BFEE57B-147A-4DD8-A27A-15DFA87AB717Q34793181-063DBCA9-780B-446F-AB20-47ED4D72CDF4Q35676808-EB5276E2-9B0D-4B01-92A7-DEC37E3A7C62Q36132197-552C15AD-19E4-47BA-A5E3-4AC4B3ADC323Q36192948-B6E9DBB7-9716-4981-81BB-F5900B7FB9CAQ36257253-87772797-4D01-41E1-96FB-A5348D411CAEQ36418451-AC4AB3D5-DC94-447A-A5EE-4EE75434B5FAQ36746421-020D7997-9413-4318-957B-19E02ED551F9Q37205221-CD89D1E6-49B2-419C-8283-212A3438B6D1Q38002880-C6295058-787D-4A94-B5B9-96874621D6F5Q38201510-BF920506-07F8-4CDE-A28E-1083D42FA66CQ38206836-49A05B14-15BA-415C-A2DE-A5152D96B0E2Q39295707-1D84AD37-54E8-4309-86EB-D1FF8C393550Q39845604-A0357144-1CD5-45BA-AC44-8D43EDE211AAQ40851415-733C2944-8AD8-4E54-B305-A5AC6F173237Q40945062-B6DB762B-087A-40D7-BA0D-466C6F4B9A46Q41724062-9731B642-37D3-41EC-9E7D-C5FBEADC474EQ42168862-E4781C5E-B8AA-4F6A-A463-6D831F6FB209Q42981519-D286496F-945C-4028-A0B2-C5C309A2C18BQ42994469-9FFFD220-3AC1-4A63-B6A6-358FFF4E9510Q42996232-D3B1259E-4A19-4EC5-BF29-BB05475B709BQ43038090-4F7CC4A3-F2BA-4107-8D1D-4715882A48CAQ43040847-E661535F-BA0A-48AA-8547-5331BF7BEBE8Q43049158-6649FF8B-603D-4E92-8D42-13E26A32910BQ43049458-2DAD8652-1887-4989-A04C-9DFABCC65491Q43118915-29F82569-6157-4042-911C-0D8A2993AA97Q43529788-5BA8E1C4-17EA-417F-B63C-ACE98C92AFDEQ43586612-598DAD1A-9D68-466A-A721-D00F0F3D85FA
P2860
Early indicators of prognosis in fulminant hepatic failure: an assessment of the King's criteria
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Early indicators of prognosis ...... essment of the King's criteria
@ast
Early indicators of prognosis ...... essment of the King's criteria
@en
Early indicators of prognosis ...... essment of the King's criteria
@nl
type
label
Early indicators of prognosis ...... essment of the King's criteria
@ast
Early indicators of prognosis ...... essment of the King's criteria
@en
Early indicators of prognosis ...... essment of the King's criteria
@nl
prefLabel
Early indicators of prognosis ...... essment of the King's criteria
@ast
Early indicators of prognosis ...... essment of the King's criteria
@en
Early indicators of prognosis ...... essment of the King's criteria
@nl
P1476
Early indicators of prognosis ...... essment of the King's criteria
@en
P2093
J M Neuberger
P Nightingale
P356
10.1016/S0168-8278(97)80010-4
P407
P50
P577
1997-01-01T00:00:00Z